REIN THERAPEUTICS INC (RNTX) Stock Price, Quote, News and Overview
NASDAQ:RNTX - Nasdaq - US00887A2042 - Common Stock - Currency: USD
RNTX Quote, Performance and Key Statistics
NASDAQ:RNTX (2/21/2025, 8:00:01 PM)
2.7
+0.02 (+0.75%)
The current stock price of RNTX is 2.7 USD. In the past month the price increased by 22.73%.
RNTX Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 19.97 | 357.10B | ||
| AMGN | AMGEN INC | 15.29 | 162.72B | ||
| GILD | GILEAD SCIENCES INC | 23.85 | 137.00B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 1669.79 | 124.40B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.34 | 76.56B | ||
| ARGX | ARGENX SE - ADR | N/A | 39.16B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 32.32B | ||
| BNTX | BIONTECH SE-ADR | N/A | 28.77B | ||
| ONC | BEIGENE LTD-ADR | N/A | 27.25B | ||
| NTRA | NATERA INC | N/A | 21.43B | ||
| BIIB | BIOGEN INC | 8.54 | 20.49B | ||
| SMMT | SUMMIT THERAPEUTICS INC | N/A | 16.31B |
Related stock screener links
About RNTX
Company Profile
Aileron Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of a novel class of therapeutics for the treatment of cancer and other diseases. The company is headquartered in Austin, Texas and currently employs 15 full-time employees. The company went IPO on 2017-06-29. The firm is advancing a pipeline of medicines to address unmet medical needs in orphan pulmonary and fibrosis indications. Its lead product candidate, LTI-03, is a synthetic peptide with a dual mechanism targeting alveolar epithelial cell survival as well as inhibition of profibrotic signaling. LTI-03 is being evaluated in a Phase Ib clinical trial for the treatment of idiopathic pulmonary fibrosis (IPF). Its second product candidate, LTI-01, is a proenzyme, or zymogen, designed to slowly activate in the pleural space and break up the scar tissue, allowing for drainage of the pleural effusion. The company has completed Phase Ib and Phase IIa clinical trials for the treatment of loculated pleural effusions.
Company Info
REIN THERAPEUTICS INC
12407 N. Mopac Expy., Suite 250 #390
Austin TEXAS US
Employees: 15
Company Website: https://aileronrx.com/
Investor Relations: http://investors.aileronrx.com/financial-information/annual-reports
Phone: 17378021989
REIN THERAPEUTICS INC / RNTX FAQ
What is the stock price of REIN THERAPEUTICS INC today?
The current stock price of RNTX is 2.7 USD. The price increased by 0.75% in the last trading session.
What is the ticker symbol for REIN THERAPEUTICS INC stock?
The exchange symbol of REIN THERAPEUTICS INC is RNTX and it is listed on the Nasdaq exchange.
On which exchange is RNTX stock listed?
RNTX stock is listed on the Nasdaq exchange.
What is REIN THERAPEUTICS INC worth?
REIN THERAPEUTICS INC (RNTX) has a market capitalization of 58.51M USD. This makes RNTX a Micro Cap stock.
How many employees does REIN THERAPEUTICS INC have?
REIN THERAPEUTICS INC (RNTX) currently has 15 employees.
Should I buy REIN THERAPEUTICS INC (RNTX) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of RNTX, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of RNTX, evaluating the profitability, health, valuation and growth aspects
- REIN THERAPEUTICS INC (RNTX) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- REIN THERAPEUTICS INC (RNTX) Sales and EPS estimates to see what analysts future expectations are.
- REIN THERAPEUTICS INC (RNTX) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- REIN THERAPEUTICS INC (RNTX) Insider and Institutional Ownership to learn about the owners and their transactions.
- REIN THERAPEUTICS INC (RNTX) Stock Chart to make your own analysis
- REIN THERAPEUTICS INC (RNTX) Latest news and press-releases to stay up to date.
Does REIN THERAPEUTICS INC (RNTX) stock pay dividends?
RNTX does not pay a dividend.
When does REIN THERAPEUTICS INC (RNTX) report earnings?
REIN THERAPEUTICS INC (RNTX) will report earnings on 2025-04-14, after the market close.
What is the Price/Earnings (PE) ratio of REIN THERAPEUTICS INC (RNTX)?
REIN THERAPEUTICS INC (RNTX) does not have a PE ratio as the earnings reported over the last twelve months were negative (-3.12).
What is the Short Interest ratio of REIN THERAPEUTICS INC (RNTX) stock?
The outstanding short interest for REIN THERAPEUTICS INC (RNTX) is 0.89% of its float. Check the ownership tab for more information on the RNTX short interest.
RNTX Technical Analysis
ChartMill assigns a technical rating of 4 / 10 to RNTX.
RNTX Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to RNTX. The financial health of RNTX is average, but there are quite some concerns on its profitability.
RNTX Financial Highlights
Over the last trailing twelve months RNTX reported a non-GAAP Earnings per Share(EPS) of -3.12. The EPS decreased by -9.65% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -28.06% | ||
| ROE | -30.71% | ||
| Debt/Equity | 0 |
RNTX Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 85% to RNTX. The Buy consensus is the average rating of analysts ratings from 8 analysts.